Facilitating scientific collaboration to accelerate antibiotic discovery

摘要

Antibiotic resistance is a dire and growing public health threat, with the United Nations projecting that by 2050 drug-resistant diseases could cause 10 million deaths globally each year. New antibiotics are urgently needed to protect patients from antibiotic-resistant "superbugs," but low returns on investment have led many pharmaceutical companies to leave the field of antibiotic research and development. David Hyun M.D.